ABSTRACT: Three trials were conducted to evaluate high levels of Zn addition from various Zn sources on growth performance and plasma Zn responses of 8-kg pigs. Zinc supplements were added to 20% CP starting diets (125 mg of Zn/kg) containing antibiotics. Trial 1 was done to evaluate plasma Zn responses of pigs fed three different feed-grade Zn sources: ZnO where supplemental Zn levels were 0, 250, 500, 1,000, 3,000, and 5,000 mgkg; ZnS04 at 1,500 or 2,500 mg of Zn/kg; and a zinc-lysine complex (Zn-Lys) a t 1,500 or 2,500 mg of Zn/kg. Plasma Zn concentration as a function of supplemental Zn intake was fitted to a broken-line for ZnO data and to simple linear models for ZnS04 and Zn-Lys data. For ZnO, plasma Zn did not increase until concentrations > 1,000 mg Zn/kg were fed. Above this level, plasma Zn increased linearly ( P < . O l ) for all three sources of Zn, although slopes of the ZnO and Zn-Lys response curves were 56% ( P < .05) and 110%, respectively, of the ZnS04 slopes. In Trial 2, five diets were fed: basal, 3,000 and 5,000 mg of Zn/kg from ZnO, and 3,000 and 5,000 mg of Zdkg from ZnS04. Daily gain and daily feed intake were increased ( P < .05) by ZnO addition, regardless of level, whereas ZnS04 addition increased these performance indices only at the 3,000 mg of Zdkg level of supplementation. Plasma Zn responses to ZnS04 addition were almost double those of ZnO addition. Trial 3 involved a basal starting diet fortified with both plasma protein and fish meal, and 3,000 mg of Zdkg from ZnO elicited gain and feed intake responses ( P < .05), whereas 3,000 mg of Znkg from ZnS04 or Zn methionine (Zn-Met) or 250 mg of Cukg from Gus04 did not elicit a response. Plasma Zn concentrations in pigs fed ZnS04 or Zn-Met were substantially higher ( P < . 0 5 ) than those in pigs fed ZnO.
Introduction
The use of pharmacological levels of Zn from ZnO has been suggested as having efficacy in controlling E. coli scours in weanling swine (Holm, 1988; Poulsen, 1989) . The levels of Zn supplementation used (2,400 t o 3,000 mg Zn/kg) are in excess of those considered safe for young pigs (Brink et al., 1959; NRC, 1988) . Other studies, however, have suggested that Zn toxicosis is either absent or much less severe when ZnO is used to supply the supplemental Zn (Cox and Hale, 1962; Hsu et al. 1975) . A lower bioavailability of Zn in ZnO than in several other sources of Zn may explain the greater tolerance for excess Zn from ZnO J. h i m . Sci. 1993. 71:3020-3024 than for other sources of Zn such as ZnS04 (Wedekind and Baker, 1990; Wedekind et al., 1992; Wedekind and Lewis, 1993) . Recent U S . studies have shown neither detrimental nor beneficial effects on pig performance from adding 3,000 mg of Zn/kg from ZnO (Fryer et al., 1992; Tokach et al., 1992) , although pigs in the study by Fryer et al. (1992) did tend to gain weight more rapidly when fed ZnO. Zinc is essential for a multitude of body functions, ranging from acidbase balance to immunocompetency, and the role of Zn as a component or activator of Zn-dependent enzymes explains most of the functional needs for Zn. The normal level of Zn in swine diets (125 mg/kg), however, should be more than adequate to satisfy these functional needs for Zn.
The objective of our study was to evaluate high levels of dietary Zn from various feed-grade Zn sources so that performance and plasma Zn concentration could be assessed under various dietary conditions. Plasma Zn concentration was monitored as a possible means by which Zn bioavailability might be assessed via a noninvasive procedure. Experimental Diets. The basal diets (Table 1 ) were formulated to meet or exceed all NRC ( 1 9 8 8 ) nutrient requirements, including Zn, of pigs between 5 and 20 kg. Antibiotics were included in the basal diets with the realization that Zn must elicit a response in their presence to be considered a commercially applicable procedure. Iron and copper, trace elements known to be antagonized by excess Zn, were present a t plethoric levels. Experimental Zn sources were analyzed for Zn by atomic absorption spectrophotometry (Model 306, Perkin-Elmer, Norwalk, CT according to procedures outlined by Wedekind et al. (1992) . Zinc concentrations were 72.0% for ZnO, 35.5% for ZnSOq.HZ0, 7.2% for Zn-lysine (Zn-Lys), and 21.9%) for Zn-methionine (Zn-Met).
Experimental Protocol and Design
TriaZ 1. Feed-grade sources of ZnO, ZnS04, and ZnLys were added to the basal diet containing 125 mg of Zn/kg diet. Zinc additions from ZnO were 250, 500, 1,000, 3,000, and 5,000 mgkg; Zn additions from ZnS04 and Zn-Lys provided 1,500 and 2,500 mgkg. Ninety pigs averaging 6.2 kg were weaned at 28 d and fed experimental diets immediately postweaning. They were assigned to diets and pens a t random from blocks based on ancestry and weight. Pigs were fed the experimental diets for 21 d. Blood samples from individual pigs were collected from the cranial vena cava region into lithium heparinized syringes a t the termination of the experiment. A portion of the blood was used for analysis of hemoglobin (Crosby et al., 1954) and hematocrit. The remainder of the blood was centrifuged (2,000 x g for 10 min). Equal volume aliquots of plasma from each sample were pooled by pen and analyzed for plasma Zn concentration by atomic absorption spectrophotometry.
Trial 2. Dietary Zn additions of 3,000 and 5,000 mg/ kg from ZnO or ZnS04 were evaluated to examine further the trend of increased gain and feed intake seen in Trial 1. Pigs were weaned a t 28 d and pretested on the basal diet (Table 1) for 7 d before initiating the trial. At 35 d of age, 150 pigs with an average initial weight of 8.33 kg were assigned to blocks based on ancestry and weight. Individual pigs within blocks were assigned randomly to experimental diets, which were fed for 21 d. Blood samples from individual pigs were collected from the cranial vena cava region at the termination of the experiment. Plasma was pooled and analyzed as in Trial 1.
Trial 3. Dietary additions of 3,000 mg of Zn/kg diet from ZnO, ZnS04, or Zn-Met were used to determine whether gain and feed intake would respond to pharmacological levels of Zn in rapidly growing pigs being fed a diet high in nutrient density. An additional treatment involved copper sulfate (CuS046H20 ) to provide a dietary level of 250 mg of Cu/kg. Pigs were weaned at 21 d and pretested for 7 d on the basal diet (Table 11 , which was designed to optimize postweaning growth. At 28 d of age, 150 pigs with an average initial weight of 7.93 kg were allotted as in Trial 2. Experimental diets were fed for 14 d and blood was obtained for Zn analysis at the termination of the trial, 
Statistical Analysis
All data were analyzed using the GLM procedure of SAS (1985) . Plasma Zn data of Trial 1 were fitted to a broken line involving one linear spline and a plateau (Robbins, 19861 , using supplemental Zn intake from ZnO as the independent variable. Plasma Zn data for ZnS04 and Zn-Lys (six data points for each) were fitted to a straight line via linear regression analysis. Weight gain data for Trial 1 were plotted against plasma Zn concentration using a second-order polynomial equation (quadratic fit) to describe the best-fit line.
Data for Trial 2 were analyzed as a factorial, using basal vs Zn ( 1 df), Zn source ( 1 df), Zn level ( 1 df), and Zn source x Zn level (1 df) as orthogonal contrasts. In Trial 3, treatment differences were evaluated using the LSD, multiple-comparison procedure of Canner and Walker (1985) . A pooled ANOVA across trials was used to establish the magnitude and significance ( P < .05) of differences between pigs fed 3,000 mgkg added Zn from ZnO and those fed the unsupplemented control diet.
Results

Trial 1. Plasma Zn concentration of pigs fed
supplemental Zn levels of 5 1,000 of mg/kg was lower ( P < .01) than that in pigs fed levels > 1,000 mg of Z d kg. The data for ZnO involving six levels of added Zn were fitted to a broken line ( R 2 = .98), and the data for ZnS04 and Zn-Lys were fitted to best-fit straight lines (Figure 1 ). The slope of the ascending portion of the ZnO response curve was 56% of the ZnS04 slope, whereas slopes for Zn-Lys and ZnS04 were virtually the same.
Performance as well as blood hemoglobin and hematocrit data involved considerable variability, and thus gain, feed intake, gain:feed, and blood hemoglobin and hematocrit did not differ ( P > .05) among treatments (data not shown). Nonetheless, Zn treatments that resulted in plasma Zn values of approximately 1.5 m g L were associated with weight gains that tended to be higher than those that resulted from pigs having plasma Zn values that were < 1.5 or > 3.0 mgL. A plot of this relationship (Figure 2 ) indicated a quadratic ( P < .05) fit.
Trial 2. Pigs in this trial involving a 7-d pretest adjustment period after weaning performed well during the 21-d assay (Table 2) . Supplemental Zn increased ( P < .05) both gain and feed intake, but the significant ( P < .05) source x level interaction indicated that both levels of ZnO increased gain and feed intake, but only the 3,000 mg of Zn/kg level from ZnS04 increased these response criteria.
Plasma Zn increased ( P < . O l ) due to Zn supplementation, and ZnS04 increased plasma Zn more ( P < .01) than did ZnO. With both sources of supplemental Zn, 5,000 mg of Znkg diet increased plasma Zn more ( P < .O 1) than 3,000 mg of Zn/kg diet did. When pooled across level, plasma Zn concentration for pigs fed ZnO was 54% of that achieved with ZnS04.
Trial 3. Pigs in this trial were fed diets containing more dried whey and also containing added fish meal and plasma protein that was not present in the diets fed in the first two trials. Copper sulfate addition did not elicit a performance response, nor did ZnS04 or Zn-Met addition (Table 3 ) . Pigs fed 3,000 mg of Zn/kg from ZnO gained faster ( P < .05) and consumed more ( P < .05) feed than pigs fed the negative control diet or any of the other experimental diets. Plasma Zn concentration was increased ( P < . 0 5 ) in pigs fed supplemental Zn, and both ZnS04 and Zn-Met increased plasma Zn more ( P < .05) than that which occurred from ZnO. Plasma Zn of pigs fed ZnO was only 55% of the value obtained from ZnS04, whereas plasma Zn of pigs fed Zn-Met was 120% of the plasma Zn value obtained with ZnSO4.
response) upon feeding young pigs 3,000 mg of Zn/kg from ZnO, but similar to our results in Trial 1 wherein pigs were placed on test immediately postweaning (28 d), the experimental variability was such as to prevent achievement of statistical significance. Plasma Zn concentrations varied across our three trials, but it was apparent that plasma Zn levels > 3 mg/L were not compatible with demonstration of efficacy from pharmacologic Zn dosing (Figure 2 , Tables 2 and 3 ) . Tokach et al. (1992) 
Discussion
Averaged across the three trials, ZnO supplementation at 3,000 mg of Zn/kg increased daily weight gains by 17% ( P < .05) and daily feed intakes by 14% ( P < .05). It was apparent that the gain responses resulted primarily from increased voluntary feed intake. These results parallel the findings of Poulsen (1989) . Fryer et al. (1992) observed increased weight gains (25% blood, thereby preventing a ZnO-induced response in weight gain.
The diet used in Trial 3 contained 20% dried whey, 3% dried porcine plasma, and 5 % fish meal; it also contained carbadox, an antibacterial growth promotant known to produce an additive growth response with copper sulfate (Roof and Mahan, 1982) . Complex diets such as this respond less to additives such as copper than is the case for simple corn-soybean meal diets (Edmonds et al., 1985) . Copper sulfate at 250 mg of Cdkg did not elicit a positive response. Added Zn from ZnS04 or Zn-Met produced greatly elevated levels of Zn in plasma, and neither feed intake nor weight gain was improved. A similar level of Zn fortification (3,000 mg/kg) from ZnO resulted in plasma Zn levels that were only one-half the levels observed in pigs fed ZnS04 or Zn-Met, and both weight gain and feed intake responded to ZnO supplementation.
Preliminary experiments in our laboratory had suggested that plasma Zn from fed pigs, but not from unfed pigs, would show consistent elevations when high levels of Zn were fed. Trial 1 represented an attempt to quantify plasma Zn responses as a function of supplemental Zn intake. Clearly, at Zn supplementation levels resulting in < 1 g/d supplemental Zn intake, plasma Zn concentration was unresponsive. It seems likely that Zn, a trace element with a fast turnover rate and short storage time (NRC, 19801 , may reach a threshold in the body where excretion cannot keep pace with absorption, resulting in linear increases in plasma Zn at Zn intakes above the threshold level. And, plasma Zn levels of approximately 1.5 mg/L were associated with a stimulation in voluntary feed intake of the pigs in our experiments.
That plasma Zn levels of pigs fed ZnO were consistently only 55% of those fed ZnS04 suggests that pigs like chickens (Wedekind and Baker, 1990; Wedekind et al., 19921, utilize Zn from ZnO far less efficiently than Zn from ZnS04. Recent evidence from Nebraska (Wedekind and Lewis, 1993) has demonstrated that bone Zn accumulation in pigs fed ZnO is only 67 to 70% as great as that in pigs fed ZnS04. Thus, plasma Zn concentration in pigs fed high levels of added Zn (between 1,000 and 5,000 mg of Zn/kg) may represent a useful and noninvasive means of assessing Zn bioavailability of various inorganic Zn sources.
The pigs used in our three trials did not exhibit diarrhea. Thus, the efficacy of ZnO for prevention of scours could not be assessed. High levels of Zn can antagonize both iron and copper (NRC, 19801 , but our diets were in considerable excess of NRC (1988) requirements for both of these trace elements. Both hemoglobin and hematocrit were assessed in Trial 1, and there were no differences in these criteria among pigs on any of the Zn levels fed in this trial.
Implications
Feeding high levels of supplemental Zn from ZnO stimulated voluntary feed intake and weight gain of young pigs that were between 28 and 49 d of age. The mechanism for the feed intake response is not known.
At pharmacologic Zn intakes, ZnS04, Zn-Lysine, and Zn-Methionine increase plasma Zn concentration far more than does ZnO. Plasma Zn concentration of pigs fed between 1,000 and 5,000 mg of Zn/kg may represent a noninvasive method of establishing relative differences in efficacy of various Zn sources.
